Rahul Gosain/LinkedIn
Feb 1, 2025, 18:04
Rahul Gosain: Discussing the recent Sub-cutaneous approval of Nivo with Saby George
Rahul Gosain, Director of Regional Infusion Services at shared a post on LinkedIn:
“Nivo was approved in Melanoma in 2014. A decade later, we’ve 20+ indications. We discuss the recent Sub-cutaneous approval of Nivo with Saby George, from Roswell Park Comprehensive Cancer Center.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 9, 2025, 16:33
Feb 9, 2025, 16:31
Feb 9, 2025, 16:27
Feb 9, 2025, 15:42
Feb 9, 2025, 15:39
Feb 9, 2025, 15:39
Feb 9, 2025, 15:35